|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5585 | |
| A61P 9/00 |
| (11) | Number of the document | 2879684 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13824807.5 |
| Date of filing the European patent application | 2013-07-30 | |
| (97) | Date of publication of the European application | 2015-06-10 |
| (45) | Date of publication and mention of the grant of the patent | 2019-01-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/052700 |
| Date | 2013-07-30 |
| (87) | Number | WO 2014/022376 |
| Date | 2014-02-06 |
| (30) | Number | Date | Country code |
| 201261678208 P | 2012-08-01 | US | |
| 201361750458 P | 2013-01-09 | US |
| (72) |
JEFFS, Roger, US
PETERSEN, Thomas, US
ILAGAN, Roger M., US
WADE, Michael, US
|
| (73) |
United Therapeutics Corporation,
1040 Spring Street, Silver Spring, MD 20910,
US
|
| (54) | TREATMENT OF PULMONARY ARTERIAL HYPERTENSION WITH PROSTACYCLIN-TREATED ENDOTHELIAL PROGENITOR CELLS |
| TREATMENT OF PULMONARY ARTERIAL HYPERTENSION WITH PROSTACYCLIN-TREATED ENDOTHELIAL PROGENITOR CELLS |